Articles Archives - Page 240 of 625

MondayNov 08, 2021 1:33 pm

SRAX Inc. (NASDAQ: SRAX) Successfully Hosts the 2021 LD Micro Main Event on October 12-14, 2021

SRAX hosted the 2021 LD Micro Main Event between October 12-14, 2021 Marking a return to an in-person conference after nearly 2 years, the event was held at both, Los Angeles’ Luxe Sunset Bel Air Hotel as well as in a virtual format The conference featured 139 companies in attendance, each of whom carried out a 25-minute presentation for the public The LD Micro Main Event is the latest highlight within an extensive conference series designed by SRAX and Sequire to offer added value to their burgeoning investor community. SRAX (NASDAQ: SRAX), a digital marketing pioneer focused on providing consumer…

MondayNov 08, 2021 12:29 pm

StraightUp Resources Inc. (CSE: ST) Positions Itself Among Major Mining Companies After Securing Right of Exclusivity with Premier Silver Corp.

StraightUp has entered an ROE with Premier Silver Corp. that secures it 60 days of exclusivity to negotiate an agreement on the acquisition of Premier and its underlying assets Premier’s acquisition would give StraightUp a shot at tremendous upside potential in silver exploration and building assets where silver forms the primary product in mining the material Premier is a crucial player in the junior mining industry, having raised over $10 million in private funding to date Its main asset, the Mallay Mine & Processing Plant, is one of the largest silver mining packages in Peru StraightUp Resources (CSE: ST) has…

MondayNov 08, 2021 11:21 am

Sugarmade Inc. (SGMD) Continues Commitment to Excellence as Cannabis Bill Creates State Regulatory Framework

Assembly Bill 45 provide clarity for the hemp industry and reassures consumers that products are independently tested and labeled properly Bill allows the sale of hemp-derived extracts that comply with testing and labeling standards SGMD, Nug Avenue committed to providing convenient mobile ordering and online access to its exclusive, quality products Keeping in line with its reputation for leading the way forward in cannabis acceptance and legislation, California lawmakers and government officials have approved an historic hemp bill (https://ibn.fm/nOjeK). The bill — Assembly Bill 45 (AB-45) — creates a comprehensive regulatory framework for the manufacture and sale of hemp-derived products in…

MondayNov 08, 2021 10:07 am

Tingo Inc. (IWBB) Poised to Deliver Transformational Impact for Societies Throughout Africa; Partners with Visa to Expand Market Footprint Across the Continent

Tingo Mobile Plc, subsidiary of leading African agri-fintech, joins forces with Visa to enhance financial services offering and drive greater adoption on its platforms Two companies share vision of bringing empowerment through access to financial services; financial inclusion is key to reducing poverty Visa is expected to help enhance Tingo's presence in Nigeria and drive expansion across the African continent and beyond The leading agri-fintech in Africa, Tingo (OTCQB: IWBB) partners with Visa Inc., in an effort to augment its offerings across Nigerian financial services and expand its market reach across Africa—the second-largest continent by population (https://ibn.fm/exiGe). With its unique…

FridayNov 05, 2021 10:39 am

German Cannabis Market Expected to Liberalize Post Election, RYAH Group Inc. (CSE: RYAH) Enters Germany Via Observational Study

German Social Democrat-led coalition expected to liberalize medical cannabis market Analysts predict over one million medical cannabis patients in Germany by 2024, market estimated to reach $8.9 billion by 2028 RYAH entered German market via observational study with Four 20 Pharma GmbH RYAH provides IoT product ecosystem of volume-control devices, medicine-carrying components, mobile applications RYAH ecosystem offers reliable way for researchers and clinicians to develop well-controlled research environments Germany’s recent 2021 election is expected to result in a new political environment via a coalition containing cannabis-positive political factions that aim to liberalize the country’s plant-based medicine market (https://ibn.fm/t1Zgg). RYAH Group…

FridayNov 05, 2021 9:30 am

InnerScope Hearing Technologies Inc. (INND) Leverages Outstanding Leadership Team to Bring New Disruptive Products and Expand Market Reach

INND appears committed to creating a leadership dream team announcing Adnan Shennib as the Company's CTO and president of international operations Shennib is a proven leader and entrepreneur in hearing medical devices; he developed several commercially successful hearing innovations INND is poised to leverage Shennib's invaluable insight and expertise to develop new disruptive products and expand Company's partnerships around the world InnerScope Hearing Technologies (OTC: INND) has announced that Adnan Shennib, a seasoned industry professional, will join as chief technology officer ("CTO") and the president of international operations responsible for expanding the Company's partnerships with manufacturers, distributors, and innovators worldwide. …

FridayNov 05, 2021 9:00 am

Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Validates its AI-Driven Drug Discovery Program with Successful Synthesis of Novel Tryptamine; Confirms Participation in the Wonderland: Miami Psychedelic Medicine Business Event

Mydecine just announced the successful synthesis of a novel psilocin analogue, a tryptamine The achievement adds to the company’s library of patent-pending tryptamines for medical use and therapy, and is seen as verifying the value of Mydecine’s AI-driven drug discovery program Mydecine has also confirmed its participation in the Wonderland: Miami psychedelic medicine event scheduled for November 8-9, 2021, where the company will share its recent research advancements and goals going forward Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) just announced the successful synthesis of a novel psilocin analogue, a tryptamine, that has proven to have improved pharmaceutical properties (https://ibn.fm/I2lX7).…

FridayNov 05, 2021 9:00 am

FuelPositive Corp. (TSX.V: NHHH) (OTCQB: NHHHF) CEO Discusses Importance of Company’s New Additions to the Management Team

September 2021 saw four new additions to FuelPositive’s management team Each of the new appointments brings with them decades of experience, technical know-how and strategic approaches that will guide the company’s future decisions and investments Ian Clifford, FuelPositive’s CEO and chair, has acknowledged that some of these appointments have come at “just the right time” Ian Clifford, the chief executive officer and chair of the board at FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF), while appearing in an interview on the company’s YouTube channel, expressed his optimism and enthusiasm about four new appointments the company made over the month of September. “It’s just a great day for us to add to our…

ThursdayNov 04, 2021 1:00 pm

Playgon Games Inc. (TSX.V: DEAL) (OTCQB: PLGNF) Experiencing Massive Growth Ahead of American Gaming Association’s Bullish 2022 Prediction

American Gaming Association’s Gaming CEO Outlook expects industry growth in 2020 driven by new hiring, wage growth, and capital investment PLGNF sees explosive growth in October 2021 with a 1500% betting handle increase, and betting turnover reached approximately $1.6 million per day from $53,500 for September PLGNF’s IP-protected iGaming software solutions include Live Dealer Casino, E-Table Games, Daily Fantasy Sports PLGNF applications run securely on any browser without app store download, do not require sharing sensitive data Playgon Games (TSX.V: DEAL) (OTCQB: PLGNF), a SaaS technology company focused on developing and licensing digital content for the growing global iGaming market,…

ThursdayNov 04, 2021 12:47 pm

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Marks Another Significant Milestone with IND Application for Fibromyalgia Phase 2a Clinical Trial

Tryp just filed an IND with the FDA for its TRP-8802 clinical candidate for its Phase 2a clinical trial The trial is set to commence in 2022, subject to a favorable review by the FDA The study will be conducted in collaboration with the University of Michigan and will aim at evaluating the safety and clinical utility of psilocybin for fibromyalgia Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) just announced its submission of an Investigational New Drug (“IND”) application to the United States Food and Drug Administration (“FDA”) for its TRP-88802 clinical candidate. This application follows the commencement of Tryp’s Phase…

Site Search

Company Search

Category: Articles